Leucine-rich repeat-containing protein 30 (LRRC30)

Leucine-rich repeat-containing protein 30 (LRRC30) is a protein coded by the human LRRC30 gene and characterized by the presence of leucine-rich repeat (LRR) motifs, which are structural domains commonly involved in protein-protein interactions[1][3]. LRRC30 is predicted to be involved in intracellular signal transduction, but there are currently no functional or mechanistic data supporting its role as a therapeutic target, receptor, enzyme, or other canonical druggable molecular class[3]. The biological role of LRRC30 is largely uncharacterized, reflecting a broader lack of functional information on many LRR-only proteins[1]. No drugs are known to interact with LRRC30, nor are there any established disease roles beyond weak associations with conditions such as middle cerebral artery infarction, for which the nature of the relationship remains unclear[3]. As such, LRRC30 should not presently be considered a defined therapeutic target, and there are no recognized biomarkers, safety concerns, or mechanisms of action relevant to this protein.

Other names

Leucine rich repeat containing 30LRRC30

None established